BWP
DNA icon

Baldwin Wealth Partners’s Ginkgo Bioworks DNA Stock Holding History

Baldwin Wealth Partners’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– -$3 – 1107
2024
Q2 		– Sell
-3
Closed -$90 – 798
2024
Q1 		$116 Hold
3
– – ﹤0.01% 689
2023
Q4 		$169 Sell
3
-15
-83% -$918 ﹤0.01% 717
2023
Q3 		$1.31K Hold
18
– – ﹤0.01% 696
2023
Q2 		$1.34K Hold
18
– – ﹤0.01% 710
2023
Q1 		$962 Hold
18
– – ﹤0.01% 755
2022
Q4 		$1.22K Buy
+18
New +$1.66K ﹤0.01% 730

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Baldwin Wealth Partners's DNA Position: Q3 2024 in Review

Baldwin Wealth Partners held its Ginkgo Bioworks (DNA) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1107.

Baldwin Wealth Partners first reported a position in DNA in Q4 2022 and has held it in 6 quarters since. The position peaked at $1.34K in Q2 2023. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Baldwin Wealth Partners held 0 shares of Ginkgo Bioworks worth $0 as of Q3 2024.
  • Baldwin Wealth Partners left its Ginkgo Bioworks share count unchanged in Q3 2024.
  • Ginkgo Bioworks made up ﹤0.01% of Baldwin Wealth Partners's portfolio in Q3 2024, its #1107 holding.
  • Baldwin Wealth Partners first reported a position in Ginkgo Bioworks in Q4 2022 and has held it in 6 quarters since.
  • Baldwin Wealth Partners's Ginkgo Bioworks position peaked at $1.34K in Q2 2023.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Baldwin Wealth Partners's 13F filing for Q3 2024, filed 16 Oct 2024.